Gioffreda Domenica

Si occupa dell'arruolamento dei pazienti con tumori del colon retto, del pancreas e dei soggetti asintomatici i cui campioni biologici sono necessari per l'identificazione di marcatori biologico-molecolari. Ha elevata esperienza nella creazione di una bio-banca e nell'estrazione degli acidi nucleici da liquidi biologici quali sangue, siero e plasma.

Informazioni aggiuntive

  • Pubblicazioni Scientifiche:

    Totale pubblicazioni a partire dal 2011: 18


    Anno

    2018; 8(1): 16389

    Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer.

    Tavano F, Gioffreda D, Valvano MR, Palmieri O, Tardio M, Latiano TP, Piepoli A, Maiello E, Pirozzi F, Andriulli A


    2018; ():

    Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study.

    Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Ca


    2017; ():

    Cancer sniffer dogs: how can we translate this peculiarity in laboratory medicine? Results of a pilot study on gastrointestinal cancers.

    Panebianco C, Kelman E, Vene K, Gioffreda D, Tavano F, Vilu R, Terracciano F, Pata I, Adamberg K, Andriulli A, Pazienza V


    2017; 26(8): 1349-1351

    Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.

    Campa D, Obazee O, Pastore M, Panzuto F, Liço V, Greenhalf W, Katzke V, Tavano F, Costello E, Corbo V, Talar-Wojnarowska R, Strobel O, Zambon CF, Neoptolemos JP, Zerboni G, Kaaks R, Key TJ, Lombardo C, Jamroziak K, Gioffreda D, Hackert T, Khaw KT, Landi


    2017; 7(): 43812

    SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.

    Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, V


    2017; ():

    Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.

    Campa D, Pastore M, Capurso G, Hackert T, Di Leo M, Izbicki JR, Khaw KT, Gioffreda D, Kupcinskas J, Pasquali C, Macinga P, Kaaks R, Stigliano S, Peeters PH, Key TJ, Talar-Wojnarowska R, Vodicka P, Valente R, Vashist YK, Salvia R, Papaconstantinou I, Shimi


    2016; ():

    Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.

    Campa D, Pastore M, Gentiluomo M, Talar-Wojnarowska R, Kupcinskas J, Malecka-Panas E, Neoptolemos JP, Niesen W, Vodicka P, Delle Fave G, Bas Bueno-de-Mesquita H, Gazouli M, Pacetti P, Di Leo M, Ito H, Klüter H, Soucek P, Corbo V, Yamao K, Hosono S, Kaaks


    2016; ():

    Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.

    Fontana A, Copetti M, Di Gangi IM, Mazza T, Tavano F, Gioffreda D, Mattivi F, Andriulli A, Vrhovsek U, Pazienza V


    2015; ():

    TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

    Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, Wang Z, Bassi C, Ryska M, Theodoropoulos GE, Kooperberg C, Li D, G


    2014; 34(9): 1369-77

    Variation in genes encoding for interferon ?-3 and ?-4 in the prediction of HCV-1 treatment-induced viral clearance.

    Palmieri O, Ippolito AM, Margaglione M, Valvano MR, Gioffreda D, Fasano M, D'Andrea G, Corritore G, Milella M, Andriulli N, Morisco F, Giannitrapani L, Latiano A, Fontana R, Gatti P, Tundo P, Barone M, Cozzolongo R, Santantonio T, Andriulli A


    XVI Congresso Nazionale SIGU 2013; : P273

    Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin

    Palmieri O., D'andrea G., De Girolamo G., Di Marco V., Margaglione M., Ippolito A.M., Fattovich G., Smedile A., Valvano M.R., Calvaruso V., Gioffreda D., Milella M., Morisco F., Felder M., Brancaccio G., Fasano M., Gatti P., Tundo P., Barone M., Cozzolong

    Società Italiana di Genetica Umana - XVI Congresso Nazionale 2013; : P321

    The TT/-G frameshift variant of the novel IFNL4 gene not improves HCV1 clearance prediction

    Palmieri O., D'andrea G. , Ippolito A.M., De Girolamo G. , Margaglione M., Latiano A., Valvano M.R., Gioffreda D., Fasano M., Milella M., Morisco F., Montalto G., Gatti P., Tundo P., Barone M., Cozzolongo R., Santantonio T., Andriulli A.

    2013; 108(7): 1112-22

    Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.

    Bruno S, Saibeni S, Bagnardi V, Vandelli C, De Luca M, Felder M, Fracanzani AL, Prisco C, Vitaliani G, Simone L, Gaeta GB, Stanzione M, Persico M, Furlan C, Stroffolini T, Salerno F, Maisonneuve P, Almasio PL, AISF (Italian Association for the Study of th


    2013; 60(1): 16-21

    Identification of Naïve Hcv-1 Patients with Chronic Hepatitis who may Benefit from Dual Therapy with Peg-Interferon and Ribavirin.

    Andriulli A, Marco VD, Margaglione M, Ippolito AM, Fattovich G, Smedile A, Valvano MR, Calvaruso V, Gioffreda D, Milella M, Morisco F, Felder M, Brancaccio G, Fasano M, Gatti P, Tundo P, Barone M, Cozzolongo R, Angelico M, D'Andrea G, Andriulli N, Abate M


    2013; 20(7): 502-9

    Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues.

    Niro GA, Ippolito AM, Fontana R, Valvano MR, Gioffreda D, Iacobellis A, Merla A, Durazzo M, Lotti G, Di Mauro L, Andriulli A


    2011; 54(4): 605A

    Long-Term Outcome Of Liver Disease In Patients With Hbv-Related Chronic Hepatitis Under Protracted Nucleos(T)Ide Analogs

    Niro GA et al.

    2011; 18(7): e206-11

    Unawareness of HBV infection among inpatients in a Southern Italian hospital.

    Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A


    2011; 43 Suppl 1(): S19-24

    Hepatitis delta virus infection: open issues.

    Niro GA, Gioffreda D, Fontana R


    {accordionfaq faqid=accordion3 faqclass="lightnessfaq defaulticon headerbackground headerborder contentbackground contentborder round5" active=0}

nuovo-css

webcamlive

Newsletter

Informativa Newsletter
  twitter   facebook   youtube   g plus